Innodata Inc. heads into its May 7 Q1 earnings report having shed 16% in a week — yet short sellers are quietly adding to positions as bulls and bears draw battle lines around an AI data services story that remains unresolved.
Short interest is the most compelling signal right now. It has climbed to 17.2% of the free float, up from roughly 14.8% at the start of April — a 16% increase on the month that has accelerated through the final week. Days to cover stand at 5.4. What makes that notable is the backdrop: the borrow market has tightened materially alongside the build. Availability has contracted from around 80-88% in early April down to roughly 55% today. That means for every two shares already borrowed, there is only a little over one remaining in the lending pool — still tight, though notably looser than the sub-47% readings seen mid-month. Borrowing costs remain low at 0.94% annualised, and have only risen modestly — up 31% over the month, but starting from a very cheap base. The ORTEX short score has ground higher all week, reaching 72.1, a multi-week high, reinforcing the picture of steady incremental pressure from short sellers rather than a sudden squeeze dynamic.
Options tell a contrasting story. Call demand has picked up sharply relative to puts. The put/call ratio has dropped to 0.46, running meaningfully below its 20-day average of 0.49 and clocking in nearly 1.2 standard deviations below that average. The 52-week range runs from 0.28 to 1.05, so this week's reading sits in the bullish half of the annual range. Options traders, in other words, are not bracing for disaster — they are leaning toward upside into the print even as short positions grow.
The Street broadly agrees with that bullish tilt. Both active coverage names maintain Outperform-or-better ratings, with targets that imply substantial upside. BWS Financial has a $110 target and reiterated its Top Pick designation as recently as April 10, while Wedbush holds a $90 Outperform. Against a current price of $39.95, the targets imply roughly two to three times current levels. Note, however, that the analyst consensus data carries a mean target of $91.25 last updated in late February — a 62-day gap that predates the recent sell-off. Neither firm has revised targets downward despite the 15% weekly pullback. Valuation multiples have eased with the share price: EV/EBITDA has compressed to 17.96, down from roughly 19.4 thirty days ago, and the PE stands near 29. EPS momentum is the factor-score standout — ranked in the 83rd percentile on 30-day EPS momentum and 79th on the 90-day measure, suggesting forward estimates have continued to drift higher even as the stock has pulled back. The ORTEX short-score rank, however, sits in just the 3rd percentile of its universe, flagging that short positioning is extreme relative to peers.
The bull case centres on more than 35% projected revenue growth, deepening Big Tech customer relationships, and a newly secured prime position in the U.S. SHIELD defence programme — the kind of revenue diversification away from hyperscalers that would raise the quality of earnings. The bear case questions whether the efficiency gains in large language models compress demand for the human-in-the-loop data preparation work that underpins Innodata's business model, and whether the stock can sustain a premium valuation while still a single-digit-earnings multiple away from speculative territory. The two most recent earnings prints are a mild caution: Q4 2025 produced a day-one decline of 4.4% and a five-day decline of 3.9%, and the prior print showed a similar -3.8% / -3.2% pattern. Neither was a blowup, but neither sparked a sustained re-rating.
Dimensional Fund Advisors added 87,000 shares in Q1, and Wellington Management added around 43,000, both adding conviction around the $50-60 price level. The institutional holder count of 188 is modest for a company with this profile, and the ownership picture does not yet signal broad institutional adoption. The most notable insider development — a cluster of senior sales including the COO — occurred in November-December 2025 at prices in the $53-65 range. That data is now over four months old and should be treated as background context rather than a current signal.
With Q1 results confirmed for May 7 and the past two prints producing modest but consistent negative reactions, the setup heading in is worth watching: short interest at a four-week high, availability tightening, and options traders positioned for upside — a configuration where a weak print and a disappointing forward guide could interact with the elevated short base in ways that amplify the move in either direction.
See the live data behind this article on ORTEX.
Open INOD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
